ConductScience.org, home

Comparison · NCT00059332-dc72cac0

Normal Saline vs Magnesium Sulfate: Modified Rankin Score of 0 or 1

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Normal Saline vs Magnesium Sulfate: Modified Rankin Score of 0 or 1. Trial comparisons, record NCT00059332-dc72cac0. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00059332-dc72cac0

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3690.3370.402wilson
Risk in group 20.3650.3340.398wilson
Risk difference, group 1 minus group 20.00369-0.0420.0494newcombe hybrid score
Risk ratio, group 1 over group 21.010.8921.14log
Odds ratio, group 1 over group 21.020.8341.24log
Number needed to treat, for one more participant with the outcome on Normal Saline than on Magnesium Sulfate271from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Normal SalineNormal Saline: Paramedics initiate a loading dose of placebo normal saline IV over 15 minutes, followed after hospital arrival by a maintenance infusion of placebo normal saline IV over 24 hours.311843OG000
Group 2Magnesium Sulfate
Magnesium Sulfate: Paramedics initiate a loading dose of 4 grams magnesium sulfate IV over 15 minutes, followed after hospital arrival by a maintenance infusion of 16 grams magnesium sulfate IV over 24 hours.
313857OG001

Outcome

Type
SECONDARY
Title
Modified Rankin Score of 0 or 1
Description
Minimal or no disability based on the modified Rankin score
Time frame
3 months
Population

Source ClinicalTrials.gov

Trial

Title
Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial
NCT number
NCT00059332
Phases
PHASE3
Conditions
Cerebrovascular Accident
Interventions
Magnesium Sulfate, Normal Saline
Lead sponsor
Jeffrey L. Saver
Results first posted
2015-08-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00059332-dc72cac0